�By manipulating the machinery used by our cells for lineament control, researchers from the University of Pittsburgh have found a way to restore the function of cystic fibrosis (CF) air passage cells. This could significantly reduce the sticky mucous secretion that plugs the lungs of CF patients, which leads to antibiotic-resistant infections and premature death. The study, coming into court in the September 2008 print subject of The FASEB Journal (www.fasebj.org), is significant because it shows a raw way to manipulate the cellular timbre controls of all sorts of proteins which play a use in conditions ranging from aging to cancer.
"Our hope is that this put to work will put up new approaches for convalescent function from the protein whose inability to folding and function properly compromises the tone of animation and life expectancies of people with CF," aforementioned Raymond Frizzell, senior generator on the study. The researchers say, however, that it is too early to state exactly what other conditions this technique will affect.
Most people do not realise that when our bodies produce proteins, they sometimes make mistakes. Similar to what happens on assembly lines, these mistakes are rejected and prevented from being secondhand. In nearly people with CF, however, defective (i.e., variation) CFTR proteins made by airway epithelial cells could actually be beneficial if they were allowed to reach their final destination at cell surfaces. To help these mutant proteins (the {DELTA}F508 CF factor mutation) progress to cell surfaces, researchers developed a "steerer," made up of only a component part of the complete mutation protein, which is rejected instead. In airway epithelial cells taken from CF patients, the "distracted" airway cells allowed the complete {DELTA}F508 CFTR protein to evade the quality ascendence mechanisms that would have normally ruined it.
"Since this pivotal find of the CF factor nearly 20 years ago, researchers feature made more progress toward a cure than they had in thousands of years earlier," said Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal. "People with cystic fibrosis now live yearner than one time ever thought possible, and basic science breakthroughs like this peerless keep the trend ever upward."
According the U.S. Cystic Fibrosis Foundation, cystic fibrosis affects about 70,000 people worldwide. It is caused by a bad gene and its protein product, which causes the body to produce selfsame thick and sticky mucous secretion. This mucous secretion clogs the lungs and leads to life-threatening lung infections. It also blocks enzymes from the pancreas that requisite to break down and absorb food. Sixty old age ago, few children with cystic fibrosis lived to attend primary school. Today, the projecting median survival age is 37.
The FASEB Journal (hTTP://www.fasebj.org/) is published by the Federation of American Societies for Experimental Biology (FASEB) and is the most cited biology journal worldwide according to the Institute for Scientific Information. FASEB comprises 21 not-for-profit societies with more than 80,000 members, qualification it the largest alliance of biomedical research associations in the United States. FASEB advances biological science through collaborative advocacy for research policies that promote scientific advancement and education and lead to improvements in human health.
Article inside information: Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia. Fei Sun, Zhibao Mi, Steven B. Condliffe, Carol A. Bertrand, Xiaoyan Gong, Xiaoli Lu, Ruilin Zhang, Joseph D. Latoche, Joseph M. Pilewski, Paul D. Robbins, and Raymond A. Frizzell. FASEB J. 2008 22: 3255-3263. doi: 10.1096/fj.07-105338 http://www.fasebj.org/cgi/content/abstract/22/9/3255
Source: Cody Mooneyhan
Federation of American Societies for Experimental Biology
More info
Monday, 1 September 2008
Subscribe to:
Posts (Atom)